BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the t… Read more
BrightBid Group AB (publ) (PERP-B) - Net Assets
Latest net assets as of December 2025: Skr30.77 Million SEK
Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has net assets worth Skr30.77 Million SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr62.22 Million) and total liabilities (Skr31.44 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr30.77 Million |
| % of Total Assets | 49.46% |
| Annual Growth Rate | 16.87% |
| 5-Year Change | 47.72% |
| 10-Year Change | 2235.23% |
| Growth Volatility | 205.4 |
BrightBid Group AB (publ) - Net Assets Trend (2012–2025)
This chart illustrates how BrightBid Group AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BrightBid Group AB (publ) (2012–2025)
The table below shows the annual net assets of BrightBid Group AB (publ) from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr30.77 Million | +183.22% |
| 2024-12-31 | Skr10.87 Million | +34.63% |
| 2023-12-31 | Skr8.07 Million | -42.48% |
| 2022-12-31 | Skr14.03 Million | -32.65% |
| 2021-12-31 | Skr20.83 Million | +39.18% |
| 2020-12-31 | Skr14.97 Million | -12.10% |
| 2019-12-31 | Skr17.03 Million | +24.07% |
| 2018-12-31 | Skr13.72 Million | +22.10% |
| 2017-12-31 | Skr11.24 Million | +752.96% |
| 2016-12-31 | Skr1.32 Million | -76.18% |
| 2015-12-31 | Skr5.53 Million | -9.67% |
| 2014-12-31 | Skr6.12 Million | +45.47% |
| 2013-12-31 | Skr4.21 Million | +3.77% |
| 2012-12-31 | Skr4.06 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BrightBid Group AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.08 Million | 5.49% |
| Other Components | Skr18.68 Million | 94.51% |
| Total Equity | Skr19.76 Million | 100.00% |
BrightBid Group AB (publ) Competitors by Market Cap
The table below lists competitors of BrightBid Group AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Totec Resources Ltd.
V:TOTC
|
$810.04K |
|
PINNACLE WEST CAP - Dusseldorf Stock Exchang
DU:PWC
|
$810.14K |
|
THEMAC RESOURCES
MU:6TH
|
$810.17K |
|
Tasfoods Ltd
AU:TFL
|
$810.25K |
|
Romios Gold Resources Inc
PINK:RMIOF
|
$809.55K |
|
Shanti Overseas (India) Limited
NSE:SHANTI
|
$809.41K |
|
LENNAR-A - Dusseldorf Stock Exchang
DU:LNN
|
$809.19K |
|
AlphaVest Acquisition Corp Right
NASDAQ:ATMVR
|
$809.00K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BrightBid Group AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,845,898 to 19,762,000, a change of 11,916,102 (151.9%).
- Net income of 2,452,000 contributed positively to equity growth.
- Other factors increased equity by 9,464,102.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr2.45 Million | +12.41% |
| Other Changes | Skr9.46 Million | +47.89% |
| Total Change | Skr- | 151.88% |
Book Value vs Market Value Analysis
This analysis compares BrightBid Group AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.80x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.22x to 0.80x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr15.64 | Skr3.40 | x |
| 2013-12-31 | Skr12.56 | Skr3.40 | x |
| 2014-12-31 | Skr18.27 | Skr3.40 | x |
| 2015-12-31 | Skr2.95 | Skr3.40 | x |
| 2016-12-31 | Skr0.65 | Skr3.40 | x |
| 2017-12-31 | Skr3.92 | Skr3.40 | x |
| 2018-12-31 | Skr1.99 | Skr3.40 | x |
| 2019-12-31 | Skr1.58 | Skr3.40 | x |
| 2020-12-31 | Skr1.06 | Skr3.40 | x |
| 2021-12-31 | Skr1.08 | Skr3.40 | x |
| 2022-12-31 | Skr0.80 | Skr3.40 | x |
| 2023-12-31 | Skr0.49 | Skr3.40 | x |
| 2024-12-31 | Skr1.74 | Skr3.40 | x |
| 2025-12-31 | Skr4.24 | Skr3.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BrightBid Group AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.41%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.84%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 3.15x
- Recent ROE (12.41%) is above the historical average (-135.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -17.70% | -338.68% | 0.04x | 1.48x | Skr-1.12 Million |
| 2013 | -46.42% | -221.70% | 0.14x | 1.49x | Skr-1.84 Million |
| 2014 | -17.26% | -104.04% | 0.13x | 1.26x | Skr-1.67 Million |
| 2015 | -135.02% | -3083.76% | 0.03x | 1.35x | Skr-8.02 Million |
| 2016 | -852.70% | -80459.69% | 0.00x | 4.65x | Skr-11.37 Million |
| 2017 | -88.47% | -1245.60% | 0.05x | 1.37x | Skr-11.07 Million |
| 2018 | -90.24% | -1196.62% | 0.06x | 1.30x | Skr-13.76 Million |
| 2019 | -98.25% | -766.68% | 0.11x | 1.19x | Skr-18.43 Million |
| 2020 | -97.46% | -767.39% | 0.10x | 1.27x | Skr-16.08 Million |
| 2021 | -65.82% | -155.54% | 0.34x | 1.23x | Skr-15.80 Million |
| 2022 | -136.58% | -189.48% | 0.54x | 1.34x | Skr-20.57 Million |
| 2023 | -226.45% | -183.95% | 0.81x | 1.53x | Skr-19.08 Million |
| 2024 | -31.52% | -35.64% | 0.37x | 2.39x | Skr-3.26 Million |
| 2025 | 12.41% | 16.84% | 0.23x | 3.15x | Skr475.80K |
Industry Comparison
This section compares BrightBid Group AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BrightBid Group AB (publ) (PERP-B) | Skr30.77 Million | -17.70% | 1.02x | $809.92K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |